Fidelity Investments
HSCS icon

Fidelity Investments’s Heart Test Laboratories HSCS Stock Holding History

Fidelity Investments’s Portfolio HSCS Stock Details HSCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.08K Buy
+736
New +$2.21K ﹤0.01% 5171
2024
Q1 		– Sell
-1
Closed -$17 – 5533
2023
Q4 		$17 Buy
+1
New +$25 ﹤0.01% 5244

Other funds holding HSCS

TFB Advisors
TFB Advisors Overland Park, Kansas $245M AUM 19.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Astoria Strategic Wealth
Astoria Strategic Wealth Conroe, Texas $441M AUM 9.4% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Allworth Financial
Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Fidelity Investments's HSCS Position: Q3 2026 in Review

Fidelity Investments opened a new position in Heart Test Laboratories (HSCS) in Q3 2026: 736 shares worth $3.08K. The stake represents ﹤0.01% of the portfolio and ranks #5171 among its holdings. This is a return to the name: Fidelity Investments previously reported a position in HSCS as recently as Q4 2023.

Fidelity Investments first reported a position in HSCS in Q4 2023 and has held it in 2 quarters since. 9 funds tracked by Wall St. Rank hold HSCS as of Q3 2026.

  • Fidelity Investments held 736 shares of Heart Test Laboratories worth $3.08K as of Q3 2026.
  • Heart Test Laboratories was a new Fidelity Investments position in Q3 2026.
  • Heart Test Laboratories made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #5171 holding.
  • Fidelity Investments first reported a position in Heart Test Laboratories in Q4 2023 and has held it in 2 quarters since.
  • 9 funds tracked by Wall St. Rank held Heart Test Laboratories as of Q3 2026.

Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.